These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 27894006

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Dysarthria enhancement mechanism under external clear speech instruction in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.
    Skrabal D, Tykalova T, Klempir J, Ruzicka E, Rusz J.
    J Neural Transm (Vienna); 2020 Jun; 127(6):905-914. PubMed ID: 32193733
    [Abstract] [Full Text] [Related]

  • 4. Acoustical analysis of speech in progressive supranuclear palsy.
    Skodda S, Visser W, Schlegel U.
    J Voice; 2011 Nov; 25(6):725-31. PubMed ID: 20457507
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Speech acoustic indices for differential diagnosis between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
    Daoudi K, Das B, Tykalova T, Klempir J, Rusz J.
    NPJ Parkinsons Dis; 2022 Oct 27; 8(1):142. PubMed ID: 36302780
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Characteristics and progression of cognitive deficits in progressive supranuclear palsy vs. multiple system atrophy and Parkinson's disease.
    Fiorenzato E, Antonini A, Camparini V, Weis L, Semenza C, Biundo R.
    J Neural Transm (Vienna); 2019 Nov 27; 126(11):1437-1445. PubMed ID: 31432258
    [Abstract] [Full Text] [Related]

  • 11. [Iodine 123-labeled meta-iodobenzylguanidine myocardial scintigraphy in the cases of idiopathic Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy].
    Yoshita M, Hayashi M, Hirai S.
    Rinsho Shinkeigaku; 1997 Jun 27; 37(6):476-82. PubMed ID: 9366173
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Assessing speech dysfunction using BOLD and acoustic analysis in parkinsonism.
    Saxena M, Behari M, Kumaran SS, Goyal V, Narang V.
    Parkinsonism Relat Disord; 2014 Aug 27; 20(8):855-61. PubMed ID: 24857769
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparative cognitive and neuropsychiatric profiles between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
    Santangelo G, Cuoco S, Pellecchia MT, Erro R, Barone P, Picillo M.
    J Neurol; 2018 Nov 27; 265(11):2602-2613. PubMed ID: 30178175
    [Abstract] [Full Text] [Related]

  • 19. Routine MRI for the differential diagnosis of Parkinson's disease, MSA, PSP, and CBD.
    Yekhlef F, Ballan G, Macia F, Delmer O, Sourgen C, Tison F.
    J Neural Transm (Vienna); 2003 Feb 27; 110(2):151-69. PubMed ID: 12589575
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.